UK proposes increase in fees, registration charge unchanged
This article was originally published in Clinica
Executive Summary
January 7 2008 is the deadline for comments on new fee proposals being put forward by the UK's Medicines and Healthcare products Regulatory Agency, the MHRA. The agency is seeking comments on proposals to change the levels of fees it charges for medical device regulatory activities covering clinical investigations, notified bodies and conformity assessment bodies.